Blephasteam
DeviceEye lid warming goggles
NCT Number: NCT01091311
Multicentric study, open label, uncontrolled phase IV in 30 patients with meibomian glands dysfunction .
Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized.
This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21.
Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.
Looking for future studies?
Notify Me4 year and older
All sexes
Interventional
Phase 4
Hôpital Gabriel Montpied, Clermont-Ferrand, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Eye lid warming goggles
Laboratoires Thea
Industry
Phase IV Multicentric Study, 30 Patients Suffering of Meibomian Glands Dysfunction.
Acronym: ESPOIR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01189474
Eye Diseases, Eyelid Diseases
Amiens, France
View Trial DetailsNCT04235803
Blepharoptosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
San Francisco, California, United States
View Trial DetailsNCT06279143
BCC, BCC - Basal Cell Carcinoma
Vejle, Region of Southern Danmark, Denmark
View Trial DetailsNCT04149210
Eye Diseases, Eyelid Diseases
Addis Ababa, Ethiopia
View Trial Details